A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: A new mechanism for selective inhibition of proteolysis

Nature Medicine

Volumn 4, Issue 8, 1998, Pages 939-944

  Sharipo, Anatoly ^a,b   Imreh, Marta ^a   Leonchiks, Ainars ^a,b   Imreh, Stefan ^a   Masucci, Maria G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b August Kirchenstein Institute of Microbiology and Virology   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; PROTEASOME; UBIQUITIN;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENE INSERTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; NUCLEOTIDE REPEAT; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; APOPTOSIS; BINDING SITES; CYSTEINE ENDOPEPTIDASES; DIPEPTIDES; DNA-BINDING PROTEINS; GENES, DOMINANT; GLYCOSYLATION; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; KINETICS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; UBIQUITINS;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0031904016     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0898-939     Document Type: Article

References (41)

1. Oldstone, M.B. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 234, 179-185 (1997).
2. Masucci, M.G. & Ernberg, I. Epstein-Barr virus: Adaptation to a life within the immune sytem. Trends Microbiol. 2, 125-130 (1994).
3. Rickinson, A.B. & Moss, D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15, 405-431 (1997).
4. Blake, N. et al. Human CD8(+) T Cell responses to EBV EBNA1 -HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7, 791-802 (1997).
5. Falk, K. et al. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis. J. Gen. Virol. 76, 779-790 (1995).
6. Levitskaya, J. et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr Virus nuclear antigen-1. Nature 375, 685-688 (1995).
7. Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A. & Masucci, M. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epsein-Barr-virus nuclear antigen 1. Proc. Natl. Acad. Sci USA 94, 12616-12621 (1997).
8. Goldberg, A.L., Akopian, T.N., Kisselev, A.F., Lee, D.H. & Rohrwild, M. New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol. Chem. 378, 131-140 (1997).
9. Berg, A.A. & Baldwin, A.S.J. The IκB proteins: multifunctional regulators of rel/NF-κB transcription factors. Genes Dev. 7, 2064-2070 (1993).
10. Brown, K., Park, S., Kanno, T., Franzoso, G. & Siebenlist, U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci USA 90, 2532-2536 (1993).
11. Henkel, T. et al. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365, 182-185 (1993).
12. DiDonato, J.A., Mercurio, F. & Karin, M. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol. Cell. Biol. 15, 1302-1311 (1995).
13. Jaffray, E., Wood, K.M. & Hay, R.T. Domain organization of I kappa B alpha and sites of interaction with NF-kappa B p65. Mol. Cell. Biol. 15, 2166-2172 (1995).
14. Rise, N.R. & Ernst, M.K. In vivo control of NF-kappaB activation by IkappaBalpha. EMBO J. 12, 4685-4695 (1993).
15. Krappmann, D., Wulczyn, F.G. & Scheidereit, C. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J. 15, 6716-6726 (1996).
16. Wang, C.Y., Mayo, M.W. & Baldwin, A.S.J. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787 (1997).
17. Beg, A.A. & Baltimore, D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782-784 (1996).
18. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789 (1996).
19. Chen, Z. et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9, 1586-1597 (1995).
20. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G. & Siebenlist, U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488 (1995).
21. Traenckner, E.B. et al. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14, 2876-2883 (1995).
22. Rodriguez, M.S. et al. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene 12, 2425-2435 (1996).
23. Miyamoto, S., Maki, M., Schmitt, M.J., Hatanaka, M. & Verma, I.M. Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B. Proc. Natl. Acad. Sci USA 91, 12740-12744 (1994).
24. Lin, Y.C., Brown, K. & Siebenlist, U. Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. Proc Natl. Acad. Sci USA 92, 552-556 (1995).
25. Finco, T.S., Beg, A.A. & Baldwin, A.S.J. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl. Acad. Sci USA 91, 11884-11888 (1994).
26. Alkalay, I. et al. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl. Acad. Sci USA 92, 10599-10603 (1995).
27. Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21 (1994).
28. Yates, J.L., Camiolo, S.M., Ali, S. & Ying, A. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222, 1-13 (1996).
29. Thiel, B.L., Guess, K.B. & Viney, C. Non-periodic lattice crystals in the hierarchical microstructure of spider (major ampullate) silk. Biopolymers 41, 703-719 (1997).
30. Simmons, A.H., Michal, C.A. & Jelinski, L.W. Molecular orientation and two-component nature of the crystalline fraction of spider dragline silk. Science 271, 84-87 (1996).
31. Williams, J., Williams, M., Liu, C. & Telling, G. Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr. Top. Microbiol. Immunol. 199, 149-175 (1995).
32. Lin, L. & Ghosh, S. A glycin-rich region of NF-kB p105 functions as a processing signal for the generation of the p50 subunit. Mol. Cell. Biol. 16, 2248-2254 (1996).
33. Harrison, P.M., Bamborough, P., Daggett, V., Prusiner, S.B. & Cohen, F.E. The prion folding problem. Curr. Opin. Struct. Biol. 7, 53-59 (1997).
34. Baumeister, W. & Lupas, A. The proteasome. Curr. Opin. Struct. Biol. 7, 273-278 (1997).
35. Fisher, E.A. et al. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J. Biol. Chem. 272, 20427-20434 (1997).
36. Lee, D.H., Sherman, M.Y. & Goldberg, A.L. Involvement of the molecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-lived and abnormal proteins in Saccharomyces cerevisiae. Mol. Cell. Biol. 16, 4773-4781 (1996).
37. Bercovich, B. et al. Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J. Biol. Chem. 272, 9002-9010 (1997).
38. DiDonato, J. et al. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16, 1295-1304 (1996).
39. Hendil, K.B., Kristensen, P. & Uerkvitz, W. Human proteasomes analysed with monoclonal antibodies. Biochem. J. 305, 245-252 (1995).
40. Devary, Y., Rosette, C., DiDonato, J.A. & Karin, M. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261, 1442-1445 (1993).
41. Dillner, J. et al. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proc. Natl. Acad. Sci USA 81, 4652-4656 (1984).